SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-22-021236
Filing Date
2022-02-14
Accepted
2022-02-14 06:20:18
Documents
1
Group Members
ROCHE HOLDING LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm226482d4_sc13ga.htm SC 13G/A 72940
  Complete submission text file 0001104659-22-021236.txt   74655
Mailing Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
Business Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
ROCHE FINANCE LTD (Filed by) CIK: 0001053942 (see all company filings)

State of Incorp.: V8
Type: SC 13G/A

Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Subject) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87213 | Film No.: 22624728
SIC: 2834 Pharmaceutical Preparations